Earlier, reports have shown that miR 17–92 cluster inhibits PTEN expression in human hepatocellular cancer and mouse lymphoproliferative disorders, and resulted in increased tumor cell proliferation, migration, and invasion [24-26]. Here, PTEN is linked to lymphoproliferative syndrome.